1. Van der Werf, N., Kroese, F. G. M., Rozing, J. & Hillebrands, J. L. Viral infections as potential triggers of type 1 diabetes. Diabetes Metab. Res. 23, 169–183 (2007).

2. Stene, L. C. et al. Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes 59, 3174–3180 (2010).

3. Laitinen, O. H. et al. Coxsackievirus B1 is associated with induction of β-cell autoimmunity that portends type 1 diabetes. Diabetes 63, 446–455 (2014).

4. Yeung, W. C., Rawlinson, W. D. & Craig, M. E. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. Br. Med. J. 342, d35 (2011).

5. Anagandula, M. et al. Infection of human islets of Langerhans with two strains of coxsackie B virus serotype 1: assessment of virus replication, degree of cell death and induction of genes involved in the innate immunity pathway. J. Med. Virol. 86, 1402–1411 (2014).

6. Krogvold, L. et al. Detection of a low-grade enteroviral infection in the islets of Langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes 64, 1682–1687 (2015).

7. Abedi, G. R. et al. Enterovirus and human parechovirus surveillance—United States, 2009–2013. Morb. Mortal. Weekly Rep. 64, 940–943 (2015).

8. Ifie, E. et al. Unexpected subcellular distribution of a specific isoform of the coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells. Diabetologia 61, 2344–2355 (2018).

9. Roivainen, M. et al. Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. J. Clin. Endocrinol. Metab. 85, 432–440 (2000).

10. Roivainen, M. et al. Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Diabetologia 45, 693–702 (2002).

11. Ajami, N. J., Wong, M. C., Ross, M. C., Lloyd, R. E. & Petrosino, J. F. Maximal viral information recovery from sequence data using VirMAP. Nat. Commun. 9, 3205 (2018).

12. Laassri, M. et al. Evolution of echovirus 11 in a chronically infected immunodeficient patient. PLoS Pathog. 14, e1006943 (2018).

13. Schneider, V. A. et al. Evaluation of GRCh38 and de novo haploid genome assemblies demonstrates the enduring quality of the reference assembly. Genome Res. 27, 849–864 (2017).

14. Tapia, G. et al. Human enterovirus RNA in monthly fecal samples and islet autoimmunity in Norwegian children with high genetic risk for type 1 diabetes: the MIDIA study. Diabetes Care 34, 151–155 (2011).

15. Honkanen, H. et al. Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity. Diabetologia 60, 424–431 (2017).

16. Simonen-Tikka, M. L. et al. Human enterovirus infections in children at increased risk for type 1 diabetes: the Babydiet study. Diabetologia 54, 2995–3002 (2011).

17. Oikarinen, S. et al. Enterovirus RNA in blood is linked to the development of type 1 diabetes. Diabetes 60, 276–279 (2011).

18. Salminen, K. et al. Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study. J. Med. Virol. 69, 91–98 (2003).

19. Cinek, O. et al. Enterovirus RNA in longitudinal blood samples and risk of islet autoimmunity in children with a high genetic risk of type 1 diabetes: the MIDIA study. Diabetologia 57, 2193–2200 (2014).

20. Lee, H. S. et al. Next-generation sequencing for viruses in children with rapid-onset type 1 diabetes. Diabetologia 56, 1705–1711 (2013).

21. Sioofy-Khojine, A. B. et al. Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes. Diabetologia 61, 1193–1202 (2018).

22. Oikarinen, S. et al. Virus antibody survey in different European populations indicates risk association between coxsackievirus B1 and type 1 diabetes. Diabetes 63, 655–662 (2014).

23. Bessaud, M., Joffret, M. L., Blondel, B. & Delpeyroux, F. Exchanges of genomic domains between poliovirus and other cocirculating species C enteroviruses reveal a high degree of plasticity. Sci. Rep. 6, 38831 (2016).

24. Hamalainen, S. et al. Coxsackievirus B1 reveals strain specific differences in plasmacytoid dendritic cell mediated immunogenicity. J. Med. Virol. 86, 1412–1420 (2014).

25. Leveque, N. et al. Functional consequences of RNA 5′-terminal deletions on coxsackievirus B3 RNA replication and ribonucleoprotein complex formation. J. Virol. 91, e00423-17 (2017).

26. Chung, P. W., Huang, Y. C., Chang, L. Y., Lin, T. Y. & Ning, H. C. Duration of enterovirus shedding in stool. J. Microbiol. Immunol. Infect. 34, 167–170 (2001).

27. Alexander, J. P. Jr., Gary, H. E. Jr. & Pallansch, M. A. Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J. Infect. Dis. 175, S176–S182 (1997).

28. Melnick, J. L. & Rennick, V. Infectivity titers of enterovirus as found in human stools. J. Med. Virol. 5, 205–220 (1980).

29. Ylipaasto, P. et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 47, 225–239 (2004).

30. Richardson, S. J., Leete, P., Bone, A. J., Foulis, A. K. & Morgan, N. G. Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1. Diabetologia 56, 185–193 (2013).

31. Busse, N. et al. Detection and localization of viral infection in the pancreas of patients with type 1 diabetes using short fluorescently-labelled oligonucleotide probes. Oncotarget 8, 12620–12636 (2017).

32. Hodik, M. et al. Coxsackie–adenovirus receptor expression is enhanced in pancreas from patients with type 1 diabetes. BMJ Open Diabetes Res. Care 4, e000219 (2016).

33. Shafren, D. R. et al. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J. Virol. 69, 3873–3877 (1995).

34. Ito, M. et al. Expression of coxsackievirus and adenovirus receptor in hearts of rats with experimental autoimmune myocarditis. Circ. Res. 86, 275–280 (2000).

35. Garnett, C. T. et al. Latent species C adenoviruses in human tonsil tissues. J. Virol. 83, 2417–2428 (2009).

36. Wang, Z. et al. Broad spectrum respiratory pathogen analysis of throat swabs from military recruits reveals interference between rhinoviruses and adenoviruses. Microb. Ecol. 59, 623–634 (2010).

37. Ingle, H. et al. Viral complementation of immunodeficiency confers protection against enteric pathogens via interferon-λ. Nat. Microbiol. 4, 1120–1128 (2019).

38. Messacar, K., Abzug, M. J. & Dominguez, S. R. 2014 outbreak of enterovirus D68 in North America. J. Med. Virol. 88, 739–745 (2016).

39. Greninger, A. L. et al. A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012–14): a retrospective cohort study. Lancet Infect. Dis. 15, 671–682 (2015).

40. Krischer, J. P. et al. Genetic and environmental interactions modify the risk of diabetes-related autoimmunity by 6 years of age: the TEDDY study. Diabetes Care 40, 1194–1202 (2017).

41. Hagopian, W. A. et al. The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr. Diabetes 12, 733–743 (2011).

42. Parkes, M., Cortes, A., van Heel, D. A. & Brown, M. A. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat. Rev. Genet. 14, 661–673 (2013).

43. Stewart, C. J. et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature 562, 583–588 (2018).

44. Vatanen, T. et al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature 562, 589–594 (2018).

45. Bonifacio, E. et al. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for National Institute of Diabetes and Digestive and Kidney Diseases consortia. J. Clin. Endocrinol. Metab. 95, 3360–3367 (2010).

46. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 37, S81–S90 (2014).

47. Lee, H. S. et al. Biomarker discovery study design for type 1 diabetes in the Environmental Determinants of Diabetes in the Young (TEDDY) study. Diabetes Metab. Res. Rev. 30, 424–434 (2014).

48. TEDDY Study Group. The Environmental Determinants of Diabetes in the Young (TEDDY) study. Ann. NY Acad. Sci. 1150, 1–13.

49. TEDDY Study Group. The Environmental Determinants of Diabetes in the Young (TEDDY) study: study design. Pediatr. Diabetes 8, 286–298 (2007).

50. Vehik, K. et al. Methods, quality control and specimen management in an international multicentre investigation of type 1 diabetes: TEDDY. Diabetes Metab. Res. Rev. 29, 557–567 (2013).

51. Clem, A. L., Sims, J., Telang, S., Eaton, J. W. & Chesney, J. Virus detection and identification using random multiplex (RT)-PCR with 3′-locked random primers. Virol. J. 4, 65 (2007).

52. Bushnell, B. BBMap Short Read Aligner (Univ. California, 2016).

53. Sioofy-Khojine, A. B. et al. Molecular epidemiology of enteroviruses in young children at increased risk of type 1 diabetes. PLoS ONE 13, e0201959 (2018).

54. Krischer, J. P. et al. The influence of type 1 diabetes genetic susceptibility regions, age, sex, and family history on the progression from multiple autoantibodies to type 1 diabetes: a TEDDY study report. Diabetes 66, 3122–3129 (2017).

55. Handbook of Modern Statistical Methods (Taylor & Francis Group, 2018).